JP2020516277A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516277A5 JP2020516277A5 JP2019555574A JP2019555574A JP2020516277A5 JP 2020516277 A5 JP2020516277 A5 JP 2020516277A5 JP 2019555574 A JP2019555574 A JP 2019555574A JP 2019555574 A JP2019555574 A JP 2019555574A JP 2020516277 A5 JP2020516277 A5 JP 2020516277A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- recombinant
- seq
- deletion
- disintegrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023020698A JP2023053298A (ja) | 2017-04-10 | 2023-02-14 | 組み換えウイルスを産生するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762483837P | 2017-04-10 | 2017-04-10 | |
| US62/483,837 | 2017-04-10 | ||
| PCT/US2018/026977 WO2018191313A1 (en) | 2017-04-10 | 2018-04-10 | Method for producing recombinant virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023020698A Division JP2023053298A (ja) | 2017-04-10 | 2023-02-14 | 組み換えウイルスを産生するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516277A JP2020516277A (ja) | 2020-06-11 |
| JP2020516277A5 true JP2020516277A5 (https=) | 2021-05-20 |
| JP7229173B2 JP7229173B2 (ja) | 2023-02-27 |
Family
ID=63792776
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555574A Active JP7229173B2 (ja) | 2017-04-10 | 2018-04-10 | 組み換えウイルスを産生するための方法 |
| JP2023020698A Withdrawn JP2023053298A (ja) | 2017-04-10 | 2023-02-14 | 組み換えウイルスを産生するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023020698A Withdrawn JP2023053298A (ja) | 2017-04-10 | 2023-02-14 | 組み換えウイルスを産生するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11999973B2 (https=) |
| EP (1) | EP3610003A4 (https=) |
| JP (2) | JP7229173B2 (https=) |
| KR (2) | KR20240032169A (https=) |
| CN (1) | CN111133102B (https=) |
| AU (1) | AU2018253088B2 (https=) |
| CA (1) | CA3059605A1 (https=) |
| WO (1) | WO2018191313A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| KR102608590B1 (ko) | 2014-09-24 | 2023-12-01 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| WO2017147269A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| JP7229173B2 (ja) * | 2017-04-10 | 2023-02-27 | エピセントアールエックス，インコーポレイテッド | 組み換えウイルスを産生するための方法 |
| CN112292449A (zh) | 2018-04-09 | 2021-01-29 | 萨克生物研究学院 | 具有增强的复制特性的溶瘤腺病毒组合物 |
| CN111793595A (zh) * | 2020-07-23 | 2020-10-20 | 上海奥浦迈生物科技有限公司 | 一种hek293细胞无血清培养基 |
| WO2024015876A1 (en) | 2022-07-13 | 2024-01-18 | Epicentrx, Inc. | Adenoviral vectors encapsulated in cationic liposomes, and preparation and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
| US6113913A (en) * | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
| AU2002348151A1 (en) | 2001-11-05 | 2003-05-19 | Genvec, Inc. | Viral vector production methods and compositions |
| EP1697505A1 (en) | 2003-12-23 | 2006-09-06 | Schering Corporation | Methods for producing a549 cell lines stable in serum-free medium suspension culture |
| JP4301558B2 (ja) | 2003-12-26 | 2009-07-22 | 日東電工株式会社 | 偏光板用接着剤、偏光板、その製造方法、光学フィルムおよび画像表示装置 |
| HUE026386T2 (en) * | 2009-03-02 | 2016-06-28 | Univ California | Tumor-selective adenovirus e1a and e1b mutants |
| EP3573632B1 (en) * | 2017-01-30 | 2024-08-07 | EpicentRx, Inc. | Tumor selective tata-box and caat-box mutant oncolytic viruses |
| JP7229173B2 (ja) * | 2017-04-10 | 2023-02-27 | エピセントアールエックス，インコーポレイテッド | 組み換えウイルスを産生するための方法 |
-
2018
- 2018-04-10 JP JP2019555574A patent/JP7229173B2/ja active Active
- 2018-04-10 KR KR1020247006527A patent/KR20240032169A/ko not_active Ceased
- 2018-04-10 AU AU2018253088A patent/AU2018253088B2/en active Active
- 2018-04-10 EP EP18785009.4A patent/EP3610003A4/en active Pending
- 2018-04-10 CN CN201880038591.8A patent/CN111133102B/zh active Active
- 2018-04-10 US US16/604,194 patent/US11999973B2/en active Active
- 2018-04-10 WO PCT/US2018/026977 patent/WO2018191313A1/en not_active Ceased
- 2018-04-10 CA CA3059605A patent/CA3059605A1/en active Pending
- 2018-04-10 KR KR1020197033110A patent/KR102643016B1/ko active Active
-
2023
- 2023-02-14 JP JP2023020698A patent/JP2023053298A/ja not_active Withdrawn
-
2024
- 2024-04-29 US US18/649,467 patent/US12291726B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516277A5 (https=) | ||
| JP2022163182A5 (https=) | ||
| CN108635380A (zh) | 重组溶瘤病毒组合物及其在制备用于治疗肿瘤的药物中的应用 | |
| JP2019523008A5 (https=) | ||
| Ahmed et al. | Long non-coding RNAs: novel players in regulation of immune response upon herpesvirus infection | |
| CN111133102B (zh) | 生产重组病毒的方法 | |
| Günther et al. | A comparative epigenome analysis of gammaherpesviruses suggests cis-acting sequence features as critical mediators of rapid polycomb recruitment | |
| Szalay et al. | Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders | |
| JP2020505049A5 (https=) | ||
| HRP20110179T1 (hr) | Kimerni adenovirusi za uporabu u liječenju raka | |
| CN1124040A (zh) | 病毒载体和基因治疗应用 | |
| WO2023165009A1 (zh) | 一种用于制备环状rna的载体及其应用 | |
| WO2005121343A1 (en) | Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof | |
| WO2020076820A3 (en) | Compositions and methods for preparing viral vectors | |
| CN104087613B (zh) | 基于aav‑itr的基因表达微载体及其构建方法和应用 | |
| Amado et al. | MicroRNA-181a regulates IFN-γ expression in effector CD8+ T cell differentiation | |
| Machitani et al. | Dicer functions as an antiviral system against human adenoviruses via cleavage of adenovirus-encoded noncoding RNA | |
| Sorel et al. | MicroRNAs in large herpesvirus DNA genomes: recent advances | |
| JP5645044B2 (ja) | 遺伝子発現制御機構を含む新規Ａｄベクター | |
| Gong et al. | Stable transfection into rat bone marrow mesenchymal stem cells by lentivirus-mediated NT-3 | |
| Wang et al. | Recombinant adenovirus vector-mediated functional expression of neurotropin-3 receptor (TrkC) in neural stem cells | |
| Machitani et al. | Development of an adenovirus vector lacking the expression of virus-associated RNAs | |
| Moy et al. | UL135 and UL136 epistasis controls reactivation of human cytomegalovirus | |
| CN101787374A (zh) | 一种基于微小rna调控可在肿瘤细胞内特异性增殖的重组腺病毒载体、其构建方法及其用途 | |
| Li et al. | Efficient editing of an adenoviral vector genome with CRISPR/Cas9 |